Patient Care: Novel Plasma Assay That Selectively Detect Tau Characteristics Will Refine Clinical Study of Alzheimer’s Disease

Written by Joni Henderson
Read more
Joni Henderson
Previous

St. Louis Magazine: C2N’s expansion into former Goodwill building boosts St. Louis’ bioscience startup ecosystem
Next

360Dx: C2N Diagnostics Inks Asia Distribution Deal for Alzheimer’s Test with Archerfish Precision Dx